Cargando…

Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease

Oxidative imbalance is one of the earliest manifestations of Alzheimer disease (AD) actually preceding the classic pathology of amyloid β deposits and neurofibrillary tangles. Clinical trials examining antioxidant modulation by a number of global interventions show efficacy, while simple supplementa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clark, Timothy A., Lee, Hyun Pil, Rolston, Raj K., Zhu, Xiongwei, Marlatt, Michael W., Castellani, Rudy J., Nunomura, Akihiko, Casadesus, Gemma, Smith, Mark A., Lee, Hyoung-gon, Perry, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Master Publishing Group 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134937/ https://www.ncbi.nlm.nih.gov/pubmed/21765811

Ejemplares similares

Treatment advances in Alzheimer's disease based on the oxidative stress model
por: Friedlich, Avi L, et al.
Publicado: (2009)

Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches
por: Castellani, Rudy J., et al.
Publicado: (2009)

Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease
por: Bryan, Kathryn J, et al.
Publicado: (2008)

Sublethal RNA Oxidation as a Mechanism for Neurodegenerative Disease
por: Castellani, Rudy J., et al.
Publicado: (2008)

RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs
por: Nunomura, Akihiko, et al.
Publicado: (2020)

A Novel Origin for Granulovacuolar Degeneration in Aging and Alzheimer’s Disease: Parallels to Stress Granules
por: Castellani, Rudy J., et al.
Publicado: (2011)

Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
por: Cardoso, Susana, et al.
Publicado: (2009)

Early Induction of Oxidative Stress in Mouse Model of Alzheimer Disease with Reduced Mitochondrial Superoxide Dismutase Activity
por: Lee, Hyun-Pil, et al.
Publicado: (2012)

Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease
por: Casadesus, Gemma, et al.
Publicado: (2007)

Alzheimer's Disease and Vascular Deficiency: Lessons from Imaging Studies and Down Syndrome
por: Reed-Cossairt, Arlene, et al.
Publicado: (2012)

Antimicrobial peptide β-defensin-1 expression is upregulated in Alzheimer’s brain
por: Williams, Wesley M, et al.
Publicado: (2013)

BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease
por: Evans, Teresa A., et al.
Publicado: (2007)

Posttranslational modifications of α-tubulin in alzheimer disease
por: Zhang, Fan, et al.
Publicado: (2015)

Oxidative Damage to RNA in Neurodegenerative Diseases
por: Nunomura, Akihiko, et al.
Publicado: (2006)

Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease
por: Bonda, David J., et al.
Publicado: (2009)

Steroidogenic Acute Regulatory Protein (StAR): Evidence of Gonadotropin-Induced Steroidogenesis in Alzheimer Disease
por: Webber, Kate M, et al.
Publicado: (2006)

Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease
por: Su, Bo, et al.
Publicado: (2009)

Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation
por: Blair, Jeffrey A., et al.
Publicado: (2016)

Correction: Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation
por: Blair, Jeffrey A., et al.
Publicado: (2016)

Amylin Pharmacology in Alzheimer’s Disease Pathogenesis and Treatment
por: Corrigan, Rachel R., et al.
Publicado: (2022)

Animal Models of Alzheimer's Disease
por: Casadesus, Gemma, et al.
Publicado: (2011)

Hibernation, a Model of Neuroprotection
por: Zhou, Fang, et al.
Publicado: (2001)

Synaptic dysfunction and oxidative stress in Alzheimer’s disease: Emerging mechanisms
por: Forero, D A, et al.
Publicado: (2006)

Targeting Gonadotropins: An Alternative Option for Alzheimer Disease Treatment
por: Casadesus, Gemma, et al.
Publicado: (2006)

Simultaneous Onset of Alzheimer’s Disease in a Husband and Wife in Their Mid-Fifties: What Do We Really Know About Environmental Factors?
por: Pelcovits, Ari, et al.
Publicado: (2015)

Alzheimer Disease Pathology in Middle Age Reveals a Spatial-Temporal Disconnect Between Amyloid-β and Phosphorylated Tau
por: Fornicola, Whitney, et al.
Publicado: (2014)

Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer's Disease
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2013)

Dementia Pugilistica Revisited
por: Castellani, Rudy J., et al.
Publicado: (2017)

Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges
por: Castellani, Rudy J., et al.
Publicado: (2019)

The Teflon hypothesis
por: Castellani, Rudy J, et al.
Publicado: (2023)

Hypothalamic–Pituitary–Gonadal Axis Involvement in Learning and Memory and Alzheimer’s Disease: More than “Just” Estrogen
por: Blair, Jeffrey A., et al.
Publicado: (2015)

Mitochondrial Drugs for Alzheimer Disease
por: Bonda, David J., et al.
Publicado: (2009)

Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
por: Wang, Wenzhang, et al.
Publicado: (2020)

Heme Deficiency in Alzheimer's Disease: A Possible Connection to Porphyria
por: Dwyer, Barney E., et al.
Publicado: (2006)

The Role of the Iron Stain in Assessing Intracranial Hemorrhage
por: Castellani, Rudy J., et al.
Publicado: (2016)

Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer's Disease Treatment: Rethinking the Current Strategy
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2012)

Cell Cycle Re-Entry and Mitochondrial Defects in Myc-Mediated Hypertrophic Cardiomyopathy and Heart Failure
por: Lee, Hyoung-gon, et al.
Publicado: (2009)

Mislocalization of CDK11/PITSLRE, a regulator of the G2/M phase of the cell cycle, in Alzheimer disease
por: Bajić, Vladan P., et al.
Publicado: (2011)

Walking Toward a Convergence in Aging Research
por: Smith, Mark A., et al.
Publicado: (2009)

Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target?
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ctisnj96fp3oh84hqpp6uffi93